Skip to main content
Market intelligence
TEVAHealthcare

Teva- Pharmaceutical Industries Ltd. ADR insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jun 18, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 18, 2026Matthew ShieldsEVP, Global OperationsSale9,989$32.19$321,547
Jun 11, 2026Eliyahu Sharon KalifEVP, Chief Financial OfficerSale106,563$34.10$3,633,308
Jun 5, 2026Richard D FrancisPresident and CEOSale6,153$34.35$211,356